These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33462301)

  • 1. Characteristics of strokes associated with centrifugal flow left ventricular assist devices.
    Inamullah O; Chiang YP; Bishawi M; Weiss M; Lutz MW; Blue LJ; Feng W; Milano CA; Luedke M; Husseini NE
    Sci Rep; 2021 Jan; 11(1):1645. PubMed ID: 33462301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
    Florisson DS; Conte SM; De Bono JA; Newcomb AE
    Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke risk following implantation of current generation centrifugal flow left ventricular assist devices.
    Chiang YP; Cox D; Schroder JN; Daneshmand MA; Blue LJ; Patel CB; DeVore AD; Bishawi M; Milano CA
    J Card Surg; 2020 Feb; 35(2):383-389. PubMed ID: 31808964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.
    Colombo PC; Mehra MR; Goldstein DJ; Estep JD; Salerno C; Jorde UP; Cowger JA; Cleveland JC; Uriel N; Sayer G; Skipper ER; Downey FX; Ono M; Hooker R; Anyanwu AC; Givertz MM; Mahr C; Topuria I; Somo SI; Crandall DL; Horstmanshof DA
    Circulation; 2019 Jan; 139(2):155-168. PubMed ID: 30586698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34491776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices.
    Frontera JA; Starling R; Cho SM; Nowacki AS; Uchino K; Hussain MS; Mountis M; Moazami N
    J Heart Lung Transplant; 2017 Jun; 36(6):673-683. PubMed ID: 28110971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of statin therapy on neurological events following left ventricular assist system implantation in advanced heart failure.
    Vieira JL; Pfeffer M; Claggett BL; Stewart GC; Givertz MM; Coakley L; Mallidi HR; Mehra MR
    J Heart Lung Transplant; 2020 Jun; 39(6):582-592. PubMed ID: 32220561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying patients at risk: multi-centre comparison of HeartMate 3 and HeartWare left ventricular assist devices.
    Numan L; Zimpfer D; Zadok OIB; Aarts E; Morshuis M; Guenther SPW; Riebandt J; Wiedemann D; Ramjankhan FZ; Oppelaar AM; Ben-Gal T; Ben-Avraham B; Asselbergs FW; Schramm R; Van Laake LW
    ESC Heart Fail; 2023 Jun; 10(3):1656-1665. PubMed ID: 36798028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrovascular Events in Patients With Centrifugal-Flow Left Ventricular Assist Devices: Propensity Score-Matched Analysis From the Intermacs Registry.
    Cho SM; Mehaffey JH; Meyers SL; Cantor RS; Starling RC; Kirklin JK; Jacobs JP; Kern J; Uchino K; Yarboro LT
    Circulation; 2021 Sep; 144(10):763-772. PubMed ID: 34315231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review.
    Cho SM; Moazami N; Frontera JA
    Neurocrit Care; 2017 Aug; 27(1):17-25. PubMed ID: 28324260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score-based analysis of long-term outcome of patients on HeartWare and HeartMate 3 left ventricular assist device support.
    Numan L; Ramjankhan FZ; Oberski DL; Oerlemans MIFJ; Aarts E; Gianoli M; Van Der Heijden JJ; De Jonge N; Van Der Kaaij NP; Meuwese CL; Mokhles MM; Oppelaar AM; De Waal EEC; Asselbergs FW; Van Laake LW
    ESC Heart Fail; 2021 Apr; 8(2):1596-1603. PubMed ID: 33635573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombus on the inflow cannula of the HeartWare HVAD: an update.
    Glass CH; Christakis A; Fishbein GA; Watkins JC; Strickland KC; Mitchell RN; Padera RF
    Cardiovasc Pathol; 2019; 38():14-20. PubMed ID: 30399526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrovascular Accidents During Mechanical Circulatory Support: New Predictors of Ischemic and Hemorrhagic Strokes and Outcome.
    Izzy S; Rubin DB; Ahmed FS; Akbik F; Renault S; Sylvester KW; Vaitkevicius H; Smallwood JA; Givertz MM; Feske SK
    Stroke; 2018 May; 49(5):1197-1203. PubMed ID: 29643259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
    Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
    Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors defining occurrence of ischemic and hemorrhagic strokes during continuous flow left ventricular assist device support.
    Tsiouris A; Heliopoulos I; Mikroulis D; Mitsias PD
    Gen Thorac Cardiovasc Surg; 2020 Apr; 68(4):319-327. PubMed ID: 31435873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Outcomes of Centrifugal Continuous-Flow Implantable Left Ventricular Assist Devices: Heartmate 3 versus Heartware Ventricular Assist Device.
    Shin K; Cho WC; Shin N; Kim HR; Kim MS; Chung CH; Jung SH
    J Chest Surg; 2024 Mar; 57(2):184-194. PubMed ID: 38360679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postimplant Phosphodiesterase-5 Inhibitor Use in Centrifugal Flow Left Ventricular Assist Devices.
    Xanthopoulos A; Wolski K; Wang Q; Blackstone EH; Randhawa VK; Soltesz EG; Young JB; Nissen SE; Estep JD; Triposkiadis F; Starling RC
    JACC Heart Fail; 2022 Feb; 10(2):89-100. PubMed ID: 35115092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
    Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
    J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Third-generation continuous-flow left ventricular assist devices: a comparative outcome analysis by device type.
    Mihalj M; Heinisch PP; Schober P; Wieser M; Martinelli M; de By TMMH; Schefold JC; Luedi MM; Kadner A; Carrel T; Mohacsi P; Hunziker L; Reineke D
    ESC Heart Fail; 2022 Oct; 9(5):3469-3482. PubMed ID: 35880515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective 1-year outcome follow-up in 200 patients supported with HeartMate 3 and HeartWare left ventricular assist devices in a single centre.
    Mueller M; Hoermandinger C; Richter G; Mulzer J; Tsyganenko D; Krabatsch T; Starck C; Stein J; Schoenrath F; Falk V; Potapov E
    Eur J Cardiothorac Surg; 2020 Jun; 57(6):1160-1165. PubMed ID: 32298426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.